Statins in Absolute Terms: Mortality Benefit, Number Needed to Treat, and the Limits of Statin Therapy in Primary and Secondary Prevention Why baseline risk, endpoint choice, follow-up duration, and residual risk determine the real-world value of LDL lowering Estimated reading time: 20 minutes
